BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
Discoveries/MEMANTINE AMANTADINE DERIVATIVE THAT HAS SOME DOPAMINERGIC EFFECTS. IT HAS BEEN PROPOSED AS
✓ X-VAULT VERIFIEDEXPLORATORYNOVELTY: LOW

MEMANTINE AMANTADINE DERIVATIVE THAT HAS SOME DOPAMINERGIC EFFECTS. IT HAS BEEN PROPOSED AS

Neurotransmitter receptors and postsynaptic signal transmission candidate

60.6
discovery score
PubMed Studies
34
Novelty
Low
Signal
Exploratory
Sealed
May 21, 2026
BiohacksAI Hypothesis

Memantine amantadine derivative that has some dopaminergic effects. it has been proposed as may modulate the Neurotransmitter receptors and postsynaptic signal transmission pathway based on its molecular target profile in the BiohacksAI corpus. This compound shows biological activity against validated targets with limited prior literature coverage, suggesting an understudied mechanism-of-action with potential research value.

Computational hypothesis based on target graph analysis. Not a confirmed mechanism. Independent experimental validation required.

Mechanism Discovery Graph
Neurotransmitter re…Transmission across…Neuronal SystemGeneric Transcripti…Post NMDA receptor …Unblocking of NMDA …GRIN2ATNNC1GRIN1TNNI3GRIN2BTNNT2MEMANTINEA…
High-value target (Tier 3)
Research target (Tier 2)
Standard target
Pathway
Biological Plausibility

The Neurotransmitter receptors and postsynaptic signal transmission pathway is a validated biological target area with established relevance in human disease and health research.

Memantine amantadine derivative that has some dopaminergic effects. it has been proposed as shows target overlap with compounds previously characterized in this pathway within the BiohacksAI corpus of 31,590 graph entities and 1.51M PubMed studies.

Low literature coverage (34 studies) relative to target engagement indicates this mechanism may be undercharacterized in current scientific literature — a signal consistent with early-stage discovery candidates.

Novelty Indicators
Literature coverage
34 PubMed studies
Low coverage = higher novelty potential
Discovery score
60.57
target_count × pathway_diversity / log(studies + 2)
Mechanism area
Neurotransmitter receptors and postsynaptic signal transmission
Primary biological pathway
Novelty rating
Low
Derived from score + literature coverage
Research Context
◈
Literature coverage
34 PubMed studies indexed at time of discovery
◈
X-Vault timestamp
Sealed May 21, 2026 — cryptographic proof of discovery date and corpus version
◈
Corpus scope
BiohacksAI corpus only — not a comprehensive literature or patent database search
◈
Mechanism area
Neurotransmitter receptors and postsynaptic signal transmission — computationally derived, requires experimental confirmation

This section reflects computational signal strength only. All findings require independent expert validation before any research or commercial use.

Suggested Validation Steps
1Neurotransmitter receptors and postsynaptic signal transmission pathway target binding assay
2Dose-response curve (EC50 determination)
3Cellular viability and selectivity panel
4In vitro ADMET profiling

Validation roadmap is algorithmically derived from pathway context. Full experimental protocol available in Priority Signal discovery reports.

Target Relevance
GRIN2A
Standard
TNNC1
Standard
GRIN1
Standard
TNNI3
Standard
GRIN2B
Standard
TNNT2
Standard

Target tier based on BiohacksAI HIGH_VALUE_TARGETS registry.

Discovery Lineage
Generated byBiohacksAI Discovery Engine
Engine versionDISCOVERY_v1.0
Corpus versioncurrent
Graph entities31,590 compounds analyzed
PubMed coverage1.51M studies
Discovery dateMay 21, 2026 at 02:00 AM UTC
X-Vault Evidence SealXVAULT_v1
Discovery IDDISC-memantine_hydrochloride-20260521-3b9a67a5
Event Hash—
Chain Hash—
Vault Index#—
Sealed At2026-05-21T02:00:02.078Z
Verify this discovery →↓ Demo PDF (X-Vault sealed)

Demo report — computational hypothesis only. Not validated. For X-Vault verification testing.

Full Discovery ReportLOCKED
🔒
Mechanism hypothesis (expanded)
Detailed molecular mechanism with target confidence scores and binding context
🔒
Complete target mapping
All validated molecular targets with affinity data and evidence levels
🔒
Biological pathway network
Full pathway coverage map with crosstalk and downstream effects
🔒
Graph position + related compounds
Structural neighbors in the BiohacksAI compound graph — potential analogs
🔒
Supporting PMIDs
Curated PubMed references with relevance ranking
🔒
X-Vault sealed PDF
Cryptographically verified 20-30 page discovery report

Interested in this discovery? Contact us for access and licensing details.

Contact us about this discovery →

All discoveries are computational hypothesis candidates — not confirmed mechanisms. Independent experimental validation is required before any research or commercial use. Organiq Sweden AB · BiohacksAI β